Why the Change?
Inteliphage is evolving. We are no longer just a research-driven biotech – we are now fully committed to bringing next-generation bacteriophage therapies into routine clinical care for patients whose health and futures depend on timely, effective treatments.
What does Inteliphage stand for?
It stands for the intelligent use of phages – alone or in combination with antibiotics – to precisely target bacterial infections, improve treatment matching, and adapt therapies as new clinical evidence emerges.
Our mission
We aim to equip healthcare professionals with smarter, affordable and practical tools to tackle persistent and drug-resistant infections, helping patients regain both health and hope.
What’s next?
We are building on solid foundations to become a globally recognised reference in phage-based medicine. By partnering with hospitals, researchers and industry, we are accelerating the transition of these powerful and synergistic therapies from bench to bedside worldwide.
To everyone who has supported us so far – and to those who will join us on this next chapter of our journey – thank you. This is just the beginning.
Inteliphage – smarter therapies for serious infections.